Results 31 to 40 of about 449,097 (277)

Hypoxemia detection and oxygen therapy practices in neonatal and pediatric wards across seven district and referral hospitals in Rwanda

Frontiers in Pediatrics
BackgroundHypoxemia, characterized by low levels of oxygen in the blood, is a potentially fatal condition that is commonly found in pediatric and neonatal conditions that drive childhood mortality globally.
Hyacinthe Mushumbamwiza, Harriet H. Webster, Christine Kayitesi, Jasmine Miller, Nang’andu Chizyuka, Felix Musabirema, Alida Ngwije, Brenda Kateera, Sanctus Musafiri, Lisine Tuyisenge, Hamish R. Graham, Felix Lam, Corneille Ntihabose   +12 more
doaj   +1 more source

Pricing of and Access to Essential Medicines in Mongolia

Central Asian Journal of Medical Sciences, 2017
No abstract in ...
Gereltuya Dorj
doaj   +1 more source

Access to Essential Medicines and Diagnostic Tests for Cardiovascular Diseases in Maputo City, Mozambique

Global Heart, 2023
Background: To tackle the increasing burden of non-communicable diseases (NCDs) and reduce premature cardiovascular (CV) mortality by a third by the year 2030, countries must achieve 80% availability of affordable essential medicines (EMs) and ...
Neusa Jessen, Abhishek Sharma, Jennifer Jones, Tangeni Auala, Sainimere Boladuadua, Ahmadou Jingi, Jose Ferrer, Ana Olga Mocumbi   +7 more
doaj   +1 more source

Improving antibiotic prescribing for children in the resource-poor setting. [PDF]

, 2015
Antibiotics are a critically important part of paediatric medical care in low- and middle-income countries (LMICs), where infectious diseases are the leading cause of child mortality. The World Health Organization estimates that >50% of all medicines are
Barker, CI, Irwin, A, Le Doare, K, Sharland, M   +3 more
core   +2 more sources

NOACs Added to WHO’s Essential Medicines List: Recommendations for Future Policy Actions

Global Heart, 2020
The introduction of non-vitamin K antagonists oral anticoagulants, a class of medicines which includes dabigatran, apixaban, edoxaban and rivaroxaban, has resulted in improvements in the safety and efficacy of non valvular atrial fibrillation treatment ...
Mariachiara Di Cesare, Jordan D. Jarvis, Oana Scarlatescu, Xinyi Leng, Ezequiel J. Zaidel, Esteban Burrone, Jean-Luc Eiselé, Dorairaj Prabhakaran, Karen Sliwa   +8 more
doaj   +1 more source

System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe. [PDF]

, 2005
Low cost and effective drugs, such as magnesium sulphate, need to be included in initiatives to improve access to essential medicines in ...
Cliff, J, Daniels, K, Fernandes, B, Lewin, S, Mariano, A, Matinhure, S, Oxman, AD, Sevene, E, Woelk, G   +8 more
core   +2 more sources

How to assure access of essential RMNCH medicines by looking at policy and systems factors: an analysis of countdown to 2015 countries

BMC Health Services Research, 2018
Background In 2000, the Millennium Development Goals set targets for social achievements by 2015 including goals related to maternal and child health, with mixed success.
Jane Briggs, Martha Embrey, Blerta Maliqi, Lisa Hedman, Jennifer Requejo   +4 more
doaj   +1 more source

Review of medicine registration system in Tanzania [PDF]

, 2019
Philosophiae Doctor - PhDRegistration of medicines is an essential function of the national medicine regulatory system of any country. Since the start of the medicine registration system in Tanzania in early 2000s, no systematic review has been carried
KISOMA, SUNDAY
core   +3 more sources

In-hospital safety in field conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. B. Gambiense Sleeping Sickness [PDF]

, 2012
Trypanosoma brucei (T.b.) gambiense Human African trypanosomiasis (HAT; sleeping sickness) is a fatal disease. Until 2009, available treatments for 2(nd) stage HAT were complicated to use, expensive (eflornithine monotherapy), or toxic, and ...
A Stanghellini, Andrea Kuemmerle, C Burri, C Schmid, Caecilia Schmid, Digas Tete, E Matovu, F Chappuis, F Checchi, G Priotto, G Priotto, G Priotto, Ismael Lumpungu, J Blum, J Blum, J Pepin, J Robays, JA Blum, Johannes Blum, Joseph Mathu Ndung'u, M Balasegaram, Mays Kisala, Medard Ilunga, Nono Mubwa, Olaf Valverde Mordt, Pathou Nganzobo, PP Simarro, Salah Ghabri, Severine Blesson, Sylvain Mutanda, Victor Kande, Wilfried Mutombo   +31 more
core   +3 more sources

A Quality Improvement Initiative to Standardize Pneumocystis jirovecii Pneumonia Prophylaxis in Pediatric Patients With Solid Tumors

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Pediatric patients with extracranial solid tumors (ST) receiving chemotherapy are at an increased risk for Pneumocystis jirovecii pneumonia (PJP). However, evidence guiding prophylaxis practices in this population is limited. A PJP‐related fatality at our institution highlighted inconsistent prescribing approaches and concerns about
Kriti Kumar, Denise M. Connolly, Ellen Kellington, Elyse Zelunka, Karla Kerrigan, Furqan Shaikh, Paul C. Nathan, Meredith S. Irwin, Sarah Cohen‐Gogo   +8 more
wiley   +1 more source